Stuart C. Ray
8Patents
1h-index
15Co-inventors
44Inventor score
Filing activity: Jan 31, 2006 → May 1, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8168771B2 | Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants | Chemistry; Metallurgy | 2 | Active |
| US12226471B2 | Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus | Chemistry; Metallurgy | 0 | Active |
| US11596679B2 | Hepatitis C virus gene sequences and methods of use therefor | Chemistry; Metallurgy | 0 | Active |
| US11660332B2 | Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus | Chemistry; Metallurgy | 0 | Active |
| US9512183B2 | Synthetic hepatitis C genome and methods of making and use | Chemistry; Metallurgy | 0 | Active |
| US10788480B2 | Aggregation-assisted separation of plasma from whole blood | Emerging Cross-Sectional Technologies | 0 | Active |
| US10188726B2 | Synthetic hepatitis C polypeptide and methods of making and using same | Chemistry; Metallurgy | 0 | Active |
| US11180758B2 | Antiviral proteins and their uses in therapeutic methods | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.